Skip to main content

Advertisement

SpringerLink
Log in

Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B

  • Letter to the editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Haemostasis Laboratory DCL, University Hospital Basel, CH-4031 Basel, Switzerland Tel. +41-61-265 2525; Fax +41-61-265 4250; e-mail tsakiris@ubaclu.unibas.ch, , , , , , CH

    D. A. Tsakiris, F. Wolf & G. A. Marbet

  2. Division of Endocrinology and Metabolism, Department of Internal Medicine, University Hospital Basel, Switzerland, , , , , , CH

    U. Keller, H. Zulewski & A. R. Miserez

Authors
  1. D. A. Tsakiris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Zulewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. R. Miserez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. A. Marbet
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 24 March 1997 / Accepted in revised form: 23 July 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsakiris, D., Keller, U., Zulewski, H. et al. Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B. E J Clin Pharmacol 53, 277–279 (1997). https://doi.org/10.1007/s002280050377

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280050377

Search

Navigation